Kallikrein 6 (KLK6) levels have been shown to be elevated in patients with multiple types of malignancies, including glioblastoma,77 colorectal,78 laryngeal,79 gastric,80 and ovarian cancers,81 as well as prostate cancer. The gene discussed is KLK6; the disease is prostate cancer.